Showing results (1-10 of 83) with videos related to
Sort By:
Pageof 9
Journal of Child Neurology|October 31, 2002
Antiangiogenesis in neurofibromatosis 1Andreas Kurtz, Robert L MartuzaOncogene|November 22, 2005
Oncolytic viral therapies - the clinical experienceManish Aghi, Robert L MartuzaNeurosurgical Focus|September 4, 2012
Postoperative imaging of vestibular schwannomasDaniel T Ginat, Robert L MartuzaJournal of the National Cancer Institute|January 5, 2006
Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replicationManish Aghi, Samuel Rabkin, Robert L MartuzaJournal for Immunotherapy of Cancer|May 28, 2020
Temozolomide antagonizes oncolytic immunovirotherapy in glioblastomaDipongkor Saha, Samuel D Rabkin, Robert L MartuzaCancer Cell|August 16, 2017
Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint BlockadeDipongkor Saha, Robert L Martuza, Samuel D RabkinCancer Research|January 20, 2007
Angiogenic response caused by oncolytic herpes simplex virus-induced reduced thrombospondin expression can be prevented by specific viral mutations or by administering a thrombospondin-derived peptideManish Aghi, Samuel D Rabkin, Robert L MartuzaCancer Research|October 19, 2006
Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vectorToshihiko Kuroda, Samuel D Rabkin, Robert L MartuzaImmunotherapy|July 17, 2018
Oncolytic herpes simplex virus immunovirotherapy in combination with immune checkpoint blockade to treat glioblastomaDipongkor Saha, Robert L Martuza, Samuel D RabkinCase Reports in Pulmonology|August 31, 2012
Anesthesia for suboccipital craniotomy in a patient with lymphangioleiomyomatosis: a case reportRobert A Peterfreund, Emily Luman, Robert L MartuzaPageof 9